Concepedia

Publication | Closed Access

Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR/Src/PAK1 pathway in lung adenocarcinoma

DOI

56

Citations

40

References

2020

Year

Runsen Jin, Xinfeng Wang, Ruochuan Zang, Chengming Liu, Sufei Zheng, Hecheng Li, Nan Sun, Jie He
Cancer Letters

References

YearCitations

Page 1